FDA clears Akebia’s drug to treat anaemia in acute kidney disease
HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia
HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia
HQ Team March 27, 2024: The size of the human brain is getting larger and the bigger size may reduce the potential of
HQ Team March 27, 2024: Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side
HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to
HQ Team March 26, 2024: The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and
HQ Team March 25, 2024: Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises
HQ Team March 23, 2024: Researchers in the UK have won a grant of $2.14 million (€1.98 million) from the Cancer Research UK
HQ Team March 22, 2024: A recent study titled “Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans” says that urban dwellers are